16 Role of Helicobacter pylori in Gastric Cancer

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 4, Issue , 2006, Pages 205-220

  Nardone, Gerardo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846377259     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(05)80078-9     Document Type: Chapter

References (124)

1. Abdel-Wahab M., Attallah A.M., Elshal M.R., Eldousoky I., Zalata K.R., el-Ghawalby N.A., Gad el-Hak N., el-Ebidy G., and Ezzat F. Correlation between endoscopy histopathol-ogy and DNA flow cytometry in patients with gastric dyspepsia. Hepatogastroenterology 43 (1996) 1313-1320
2. Asaka M., Kudo M., Kato M., Sugiyama T., and Takeda H. Review article: long-term Helicobacter pylori infection-from gastritis to gastric cancer. Aliment. Phannacol. Ther. 12 (1998) 9-15
3. Asaka M., Sugiyama T., Nobuta A., Kato M., Takeda H., and Graham D.Y. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6 (2001) 294-299
4. Atherton J.C. The clinical relevance of strain types of Helicobacter pylori. Gut. 40 (1997) 701-703
5. Atherton J.C., Peek R.M., Tham K.T., Cover T.L., and Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 (1997) 92-99
6. Azuma T., Ito S., Sato R., Yamazaki Y., Miyaji H., Ito Y., Suto H., Kuriyama M., Kato T., and Kohli Y. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 82 (1998) 1013-1018
7. Baggiolini M., Dewald D., and Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55 (1994) 97-179
8. Beales I.L., and Calam J. Interleukin lbeta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 42 (1998) 227-234
9. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113 (2004) 321-333
10. Blaser M.J., Chyou P.H., and Nomura A. Age at establish-ment of Helicobacter pylori infection and gastric carcinoma gastric ulcer and duodenal ulcer risk. Cancer Res. 55 (1995) 562-565
11. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., and Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adeno-carcinoma of the stomach. Cancer Res. 55 (1995) 2111-2115
12. Milano. Borchard F. Precancerous conditions and lesions of stomach. In: Rugge M., Arslan-Pagnini C., and Di Mario F. (Eds). Edizioni Uniscop (1986) 175
13. Brenner H., Arndt V., Sturmer T., Stegmaier C., Zeigtec H., and Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 88 (2000) 214-219
14. Cassaro M., Rugge M., Gutierrez O., Leandro G., Graham D.Y., and Genta R.M. Topographic patterns of intestinal meta-plasia and gastric cancer. Am. J. Gastroenterol 95 (2000) 1431-1438
15. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., and Covacci A. Cag a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93 (1996) 14648-14653
16. Cheli R., Giacosa A., and Pirasso A. Chronic gastritis: a dynamic process toward cancer. In: Ming S.C. (Ed). Precursor of gastric cancer (1984), Praeger Scientific, New York 777
17. Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 19 (1995) 37-43
18. Correa P., Fontham E.T., Bravo J.C., Bravo L.E., Ruiz B., Zarama G., Reale J.L., Malcom G.T., Li D., Johnson W.D., and Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacterpylori therapy. J. Natl. Cancer. Inst. 92 (2000) 1881-1888
19. Craanen M.E., Blok P., Dekker W., Offerhaus G.J.A., and Tytgat G.N.J. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut. 36 (1995) 848-852
20. Crabtree J.E. Gastric mucosal inflammatory response to Helicobacter pylori. Aliment. Pharmacol. Then. 10 (1996) 29-37
21. Del Prete G. The concept of Type-1 and Type-2 helper T cells and their cytokines in humans. Intern. Rev. Immunol. 16 (1998) 427-455
22. D'Elios M.M., Amedei A., and Del Prete G. Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymp. Microb. Infect. 5 (2003) 723-730
23. Dixon M.F. Prospects for intervention in gastric carcino-genesis: reversibility of gastric atrophy and intestinal metaplasia. Gut. 49 (2001) 2-4
24. Drake I.M., Mapstone N.P., Schorah C.J., White K.L., Chalmers D.M., Dixon M.F., and Axon A.T. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations. Gut. 42 (1998) 111-168
25. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
26. El-Zimaity H.M., and Graham D.Y. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum. Pathol. 30 (1999) 72-77
27. EUROGAST S.Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 (1993) 1359-1363
28. Everett S.M., White K.L., Drake L.M., Schorah C.J., Calvert R.J., Skinner C., Stringer M.D., Miller D., Dixon M.F., Chalmers D.M., and Axon A.T. The effect of Helicobacter pylori infection on levels of DNA damage in gastric epithelial cells. Helicobacter 7 (2002) 271-280
29. Farinati E., Cardin R., Degan P., Rugge M., Mario F.D., Bonvicini P., and Naccarato R. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut. 42 (1998) 351-356
30. Fenoglio-Preiser C., Carneiro E., and Cornea P. Gastric carcinoma. In: Hamilton S.R., and Aaltonen L.A. (Eds). Pathology and genetics tumors of the digestive system (2000), IARC, Lyon 39
31. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., Carvaiho R., Capelinha A.F., Quint W., Caldas C., Van Doom L.J., Carneiro E., and Sobrinho-Simoes M. Helicobacter pylori and interleukin 1 genotyping: an opportu-nity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 94 (2002) 1680-1687
32. Filipe M.I., Munoz N., Matko I., Kato L., Pompe-Kirn V., Jutersek A., Teuchmann S., Benz M., and Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 57 (1994) 324-329
33. Fox J.G., Beck P., Dangler C.A., Whary M.T., Wang T.C., Shi H.N., and Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat. Med. 6 (2000) 536-542
34. Fox J.G., Rogers A.B., Ihrig M., Taylor N.S., Whary M.T., Dockray G., Varro A., and Wang T.C. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63 (2003) 942-950
35. Fuchs C.S., and Mayer R.J. Gastric carcinoma. N. Engl. J. Med. 333 (1995) 32-41
36. Genta R.M., and Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut. 45 (1999) 15-18
37. Gonzalez C.A., Sala N., and Capella G. Genetic suscepti-bility and gastric cancer risk. Int. J. Cancer 100 (2002) 249-260
38. Graham D.Y., and Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 5 (2000) 279-282
39. Han S.U., Kim Y.B., Joo H.J., Hahm K.B., Lee W.H., Cho Y.K., Kim D.Y., and Kim M.W. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J. Gastroenterol Hepatol 17 (2002) 253-261
40. Helicobacter C.C.G. Gastric can-cer and Helicobacter pylori: a combined analysis of 12 case con-trol studies nested within prospective cohorts. Gut. 49 (2001) 347-351
41. Hohenberger P., and Gretschel S. Gastric cancer. Lancet 362 (2003) 305-315
42. Hojo M., Miwa H., Ohkusa T., Ohkura R., Kurosawa A., and Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment. Pharmacol. Then 16 (2002) 1331-1332
43. Holcombe C. Helicobacter pylori: the African enigma. Gut. 33 (1992) 429-433
44. Houghton J., Fox J.G., and Wang T.C. Helicobacter pylori and other causes of gastric ulceration. J. Gastroenterol. Hepatol. 17 (2002) 495-499
45. Huang J.Q., Sridhar S., Chen Y., and Hunt R.H. Meta-analysis of the relationship between Helicobacter pylori seropos-itivity and gastric cancer. Gastroenterology 114 (1998) 1169-1172
46. Inoue M., Tajima K., Matsuura A., Suzuki T., Nakamura T., Ohashi K., Nakamura S., and Tominaga S. Severity of chronic atrophic gastritis and subsequent gastric cancer occur-rence: a 10-year prospective cohort study in Japan. Cancer Lett. 161 (2000) 105-112
47. International A.f.R.o.C. Schistosomes liver flukes and Helicobacter pylori. IARC 61 (1994) 177
48. Ishikawa N., Wakelin D., and Mahida YR. Role of T helper 2 cells in intestinal goblet cell hyperplasia in mice infected with Trichinella spiralis. Gastroenterology 113 (1997) 542-549
49. Jass J.R., and Filipe M.I. Suiphomucins and precancerous lesions of the human stomach. Histopathology 4 (1980) 271-279
50. Karnes Jr. W.E., Samloff I.M., Siurala M., Kekki M., Sipponen P., Kim S.W., and Walsh J.H. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 101 (1991) 167-174
51. Kikuchi S., Crabtree J.E., Forman D., and Kurosawa M. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults: Research Group on P. Am. J. Gastroenterol 94 (1999) 3455-3459
52. Kikuchi S., Wada O., Nakajima T., Nishi T., Kobayashi O., Konishi T., and Inaba Y. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults: Research Group on Prevention of Gastric Carcinoma Among Young Adults. Cancer 75 (1995) 2789-2793
53. Kobayashi M., Tsubono Y., Sasazuki S., Sasaki S., and Tsugane S. Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC study Cohort I. Int. J. Cancer 102 (2002) 39-44
54. Koehler C.I., Mues M.B., Dienes H.P., Kriegsmann J., Schirmacher P., and Odenthal M. Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol. Pathol. 56 (2003) 36-42
55. Konturek P.C., Rembiasz K., Konturek S.J., Stachura J., Bielanski W., Galuschka K., Karcz D., and Hahn E.G. Gene expression of ornithine decarboxylase cyclooxygenase-2 and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradicat. Dig. Dis. Sci. 48 (2003) 36-46
56. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
57. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path. Microbiol. Scand. 64 (1965) 31-38
58. Lee J.E., Lowy A.M., Thompson W.A., Lu M., Loflin P.T., Skibber J.M., Evans D.B., Curley S.A., Mansfield P.F., and Reveille J.D. Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology 111 (1996) 426-432
59. Leung W.K., and Sung J.J. Review article: intestinal meta-plasia and gastric carciogenesis. Aliment. Pharmacol. Ther. 16 (2002) 1209-1216
60. Li C.Q., Pignatelli B., and Ohshima H. Increased oxidative and nitrative stress in human stomach associated with cagAHelicobacter pylori infection and inflammation. Dig. Dis. Sci. 46 (2001) 836-844
61. Li J., Zhao A., Lu Y., and Wang Y. Expression of pl85erbB2 and p21ras in carcinoma, dysplasia, and intestinal metaplasia of the stomach: an immunohistochemical and in situ hybridization study. Semin. Surg. Oncol. 10 (1994) 95-99
62. Li L., Genta R.M., Go M.F., Gutirrez O., Kim J.G., and Graham D.Y. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter 7 (2002) 349-355
63. Louw J.A., Kidd M.S., Kummer A.F., Taylor K., Kotze U., and Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 6 (2001) 268-273
64. Lunet N., and Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int. J. Cancer 106 (2003) 953-960
65. Lynch D.A., Mapstone N.P., Clarke A.M., Sobala G.M., Jackson P., Morrison L., Dixon M.F., Quirke P., and Axon A.T. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 36 (1995) 346-350
66. Magnusson P.K.E., Enroth H., Eriksson I., Held M., Nyren O., Engstrand L., Hansson L.E., and Gyllensten U.B. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res. 61 (2001) 2684-2689
67. Malfertheiner P., Megraud F., O'Morain C., Hungin A.P., Jones R., Axon A., Graham D.Y., and Tytgat G. European Helicobacter Pylori Study Group (EHPSG) 2002. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Re. Aliment. Pharmacol. Ther. 16 (2002) 167-180
68. McColl K.E., El-Omar E., Gillen D., and Banerjee S. The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer. Semin. Gastrointest. Dis. 8 (1997) 142-155
69. Ming S.C. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1 (1998) 31-50
70. Mitchell H.M., Hazell S.L., Li Y.Y., and Hu P.J. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am. J. Gastroenterol. 2 (1996) 1785-1788
71. Mitchell H.M., Li Y.Y., Hu P.J., Liu Q., Chen M.L., Du G.G., Wang Z.J., Lee A., and Hazell S.L. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as the critical period for acquisition. J. Infect. Dis. 166 (1992) 149-153
72. Miyaji H., Azuma T., Ito S., Abe Y., Gejyo R., Hashimoto N., Sugimoto H., Suto H., Ito Y., Yamazaki Y., Kohli Y., and Kuriyama M. Helicobacter pylori infection occurs via close contact with infected individuals in early childhood. J. Gastmenterol. HepatoL 15 (2000) 257-262
73. Moss S.F. Cellular markers in the gastric precancerous process. Aliment. Pharmacol. Ther. 1 12 Suppl. (1998) 91-109
74. Nardone G. Review article: molecular basis of gastric carcinogenesis. Aliment. Pharmacol. Ther. 2 17 Suppl. (2003) 75-81
75. Nardone G., D'Armiento P., Corso G., Coscione P., Esposito M., and Budillon G. Lipids of human gastric mucosa: effect of Helicobacter pylori infection and nonalcoholic cirrhosis. Gastmenterology 107 (1993) 362-368
76. L: a molecular pathway of Helicobacter pylori -related gastric carcinogenesis. J. Pathol. 202 (2004) 305-312
77. Nardone G., Staibano S., Rocco A., Mezza E., Balzano T., Salvatore G., Staiano A., Donofrio V., Grazioli B., De Rosa G., and Budillon G. Effect of Helicobacter pylori infec-tion on gastric cell proliferation and genomic instability in a paediatric population of Southern Italy. Digest. Liver. Dis. 33 (2001) 743-749
78. Nardone G., Staibano S., Rocco A., Mezza E., D'armiento F.P., Insabato L., Coppola A., Salvatore G., Lucariello A., Figura N., De Rosa G., and Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastri-tis. Gut. 44 (1999) 789-799
79. Nogueira C., Figueiredo C., Carneiro F., Gomes A.T., Barreira R., Figueira P., Salgado C., Belo L., Peixoto A., Bravo J.C., Bravo L.E., Reale J.L., Plaisier A.P., Quint W.G., Ruiz B., Cornea P., and Van Doom L.J. Helicobacter pylori genotypes may determine gastric histopathology. Am. J. Pathol. 158 (2001) 647-654
80. O'Connor H.J. Helicobacter pylori and gastric cancer: a review and hypothesis. Eur. J. Gastmenterol. Hepathol. 4 (1992) 103
81. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., and Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287 (2000) 1497-1500
82. Ohata H., Kitauchi S., Yoshimura N., Mugitani K., Iwane M., Nakamura H., Yoshikawa A., Yanaoka K., Arii K., Tamai H., Shimizu Y., Takeshita T., Mohara O., and Ichinose M. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int.J. Cancer. 109 (2004) 138-143
83. Parkin D.M., Bray R., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J. Clin. 55 (2005) 74-108
84. Parsonnet J., Friedman G.D., Orentreich N., and Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 40 (1997) 297-301
85. 1992. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., and Sibley R.K. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325 (1991) 1127-1131
86. Parsonnet J., Harris R.A., Hack H.M., and Owens D.K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348 (1996) 150-154
87. Ren Z., Pang G., Clancy R., Li L.C., Li C.S., Batey R., Borody T., and Dunkley M. Shift of the gastric T-cell response in gastric carcinoma. J. Gastmenterol. HepatoL 16 (2001) 142-148
88. Rocco A., Staiano S., Ottini L., Mezza E., Somma P., Mariani-Costantini R., Budillon G., and Nardone G. Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. Eur. J. Cancer 39 (2003) 1619-1624
89. Rokkas T., Ladas S., Liatsos C., Petridou E., Papatheodorou G., Theocharis S., Karameris A., and Raptis S. Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig. Dis. Sci. 44 (1999) 487-492
90. Rugge M., Cassaro M., Di Mario R., Leo G., Leandro G., Russo V.M., Pennelli G., and Farinati R. The long term outcome of gastric non-invasive neoplasia. Gut. 52 (2003) 1111-1116
91. Rugge M., Correa P., Dixon M.R., Fiocca R., Hattori T., Lechago J., Leandro G., Price A.B., Sipponen P., Solcia E., Watanabe H., and Genta R.M. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment. Pharmacol. Ther. 16 (2002) 1249-1259
92. Russo R., Linsalata M., Giorgio I., Caruso M.L., Armentano R., and Di Leo A. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma. Dig. Dis. Sci. 42 (1997) 576-579
93. Sanduleanu S., Jonkers D., De Bruine A., Hameeteman W., and Stockbrugger R.W. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines. Aliment. Pharmacol. Ther. 15 (2001) 1163-1175
94. Sasazuki S., Sasaki S., and Tsugane S. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subside and histologic type. Int. J. Cancer 101 (2002) 560-566
95. Satoh K. Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan. Gastmenterol. Clin. North Am. 29 (2000) 829-835
96. Satoh K., Mutoh H., Eda A., Yanaka I., Osawa H., Honda S., Kawata H., Kihira K., and Sugano K. Aberrant expres-sion of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter 7 (2002) 192-198
97. Schlemper R.J., Itabashi M., Kato Y., Lewin K.J., Riddell R.H., Shimoda T., Sipponen P., Stolte M., Watanabe H., Takahashi H., and Fujita R. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 349 (1997) 1725-1729
98. Schlemper R.J., Riddell R.H., Kato Y., Borchard R., Cooper H.S., Dawsey S.M., Dixon M.R., Fenoglio-Preiser C.M., Flejou J.R., Geboes K., Hattoni T., Hirota T., Itabashi M., Iwafuchi M., Iwashita A., Kim Y.I., Kirchner T., Klimpfinger M., Koike M., Lauwers G.Y., Lewin K.J., Oberhuber G., Offner R., Price A.B., Rubio C.A., Shimizu M., Shimoda T., Sipponen P., Solcia E., Stolte M., Watanabe H., and Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 47 (2000) 251-255
99. Scotiniotis I.A., Rokkas T., Furth E.E., Rigas B., and Shiff S.J. Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: implications for gastric carcinogenesis. Int. J. Cancer 85 (2000) 192-200
100. Sepulveda A.R. Molecular testing of Helicobacter pylori-associated chronic gastritis and premalignant gastric lesions: clinical implications. J. Clin. Gastmenterol. 32 (2001) 377-382
101. Shimizu N., Ikehara Y., Inada K., Nakanishi H., Tsukamoto T., Nozaki K., Kaminishi M., Kuramoto S., Sugiyama A., Katsuyama T., and Tatematsu M. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res. 60 (2000) 1512-1514
102. Shimoyama T., and Crabtree J.E. Mucosal chemokines in Helicobacter pylori infection. J. Physiol Pharmacol 48 (1997) 315
103. Shimoyama T., Fukuda S., Tanaka M., Nakaji S., and Munakata A. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori. Virchows Arch. 436 (2000) 585-587
104. Silberg D.G., Furth E.E., Taylor J.K., Schuck T., Chiou T., and Traber P.G. CDX1 protein expression in normal metaplastic and neoplastic human alimentary tract epithelium. Gastroenterology 113 (1997) 478-486
105. Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R., Ghiara P., and Smith P.D. Helicobacter pylori-induced mucosal inflammation is Thl mediated and exacerbated in IL-4 but not IFN-gamma, gene-deficient mice. J. Immunol. 165 (2000) 1022-1029
106. Staibano S., Rocco A., Mezza E., De Rosa G., Budillon G., and Nardone G. Diagnosis of chronic atrophic gastritis by morphometric image analysis: a new method to overcome the confounding effect of the inflammatory infiltrate. J. Pathol. 198 (2002) 41-54
107. Stolte M., Meining A., Schmitz J.M., Alexandridis T., and Seifert E. Changes in Helicobacter pylori-induced gas-tritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gas. Aliment. Pharmacol. Then 12 (1998) 247-253
108. Sung J.J., Lin S.R., Ching J.Y., Zhou L.Y., To K.F., Wang R.T., Leung W.K., Ng. E.K., Lau J.Y., Lee Y.T., Yeung C.K., Chao W., and Chung S.C. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119 (2000) 7-14
109. Tahara B. Molecular biology of gastric cancer. World J. Surg. 19 (1995) 88-484
110. Tatematsu M., Nozaki K., and Tsukamoto T. Helicobacter pylori infection and gastric carcinogenesis in animal models. Gastric Cancer 6 (2003) 1-7
111. Tepes B., Kavcic B., Zaletel L.K., Gubina M., Ihan A., Poljak M., and Krizman I. Two-to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J. Pathol. 188 (1999) 24-29
112. Testino G., Valentini M., Cornaggia M., and Testino R. Chronic atrophic gastritis and gastric cancer. Digest. Liver Dis. 32 (2000) 544
113. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., and Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345 (2001) 784-789
114. van Doom L.J., Figueiredo C., Megraud E., Pena S., Midolo P., Queiroz D.M., Carneiro E., Vanderborght B., Pegado M.D., Sauna R., De Boer W., Schneeberger P.M., Correa P., Ng E.K., Atherton J., Blaser M.J., and Quint W.G. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116 (1999) 823-830
115. Van Doom L.J., Figueiredo C., Sanna R., Pena S., Midolo P., Ng E.K., Atherton J.C., Blaser M.J., and Quint W.G. Expanding allelic diversity of Helicobacter pylori vac A. J. Clin. Microbiol. 36 (1998) 2591-2603
116. Warren J.R., and Marshall B.J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 (1983) 1273-1277
117. Watanabe T., Tada M., Nagai H., Sasaki S., and Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115 (1998) 642-648
118. Weisburger J.H., and Chung F.L. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea poly phenols. Food Chem. Toxicol. 40 (2002) 1145-1154
119. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., Lai K.C., Hu W.H., Yuen S.T., Leung S.Y., Fong D.Y., Ho J., Ching C.K., and Chen J.S. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 297 (2004) 187-194
120. Wu A.H., Crabtree J.E., Bernstein L., Hawtin P., Cockbum M., Tseng C.C., and Forman D. Role of Helicobacter pylori CagAstrains and risk of adenocarcinoma of the stomach and esophagus. Int. J. Cancer 103 (2003) 815-821
121. Yang Y.L., Xu B., Song Y.G., and Zhang W.D. Overexpression of c-fos in Helicobacter pylori-induced gastric precancerosis of Mongolian gerbil. World J. Gastroenterol. 9 (2003) 521-524
122. You W.C., Li J.Y., Blot W.J., Chang Y.S., Jin M.L., Gail M.H., Zhang L., Liu W.D., Ma J.L., Hu Y.R., Mark S.D., Cornea P., Fraumeni Jr. J.F., and Xu G.W. Evolution of precancer-ous lesions in a rural Chinese population at high risk of gastric cancer. Int. J. Cancer 83 (1999) 615-619
123. Zanghieri G., Di Gregorio C., Sacchetti C., Fante R., Passatelli R., Canonizzo G., Carriero A., and Ponz de Leon M. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66 (1990) 2047-2051
124. Zullo A., Rinaldi V., Hassan C., Diana E., Winn S., Castagna G., and Attili A.F. Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study. Aliment. Pharmacol. Ther. 14 (2000) 1303-1309